Literature DB >> 8504985

Pelvic lymphadenectomy in the surgical treatment of endometrial cancer.

F Girardi1, E Petru, M Heydarfadai, J Haas, R Winter.   

Abstract

Between 1982 and 1991, 76 of 322 (24%) patients with primary endometrial adenocarcinoma and morphologic risk factors underwent surgery including systematic pelvic lymphadenectomy (LA). A mean number of 37 lymph nodes per patient was removed. The number of removed nodes did not differ with respect to mode of LA, FIGO stage, depth of myometrial invasion, and histologic subtype or grade. Twenty-seven of 76 (36%) patients had lymph node metastases; 37% of lymph node metastases were < or = 2 mm in diameter. The incidence of lymph node metastases correlated significantly with the depth of myometrial invasion but not with histologic subtype and grade. Twenty-four patients with positive nodes who had stage I disease according to the clinical classification (FIGO 1971) were upstaged to stage IIIc according to the surgical staging system (FIGO 1988). This study underlines the need for complete, systematic LA and the need for thorough histologic processing with step-serial sections for correct staging of patients with endometrial cancer.

Entities:  

Mesh:

Year:  1993        PMID: 8504985     DOI: 10.1006/gyno.1993.1103

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  Current status in the management of uterine corpus cancer in Korea.

Authors:  Nan-Hee Jeong; Jong-Min Lee; Seon-Kyung Lee
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401

Review 2.  The role of para-aortic lymphadenectomy in endometrial cancer.

Authors:  Mariam M AlHilli; Andrea Mariani
Journal:  Int J Clin Oncol       Date:  2013-02-15       Impact factor: 3.402

3.  Obesity does not affect the number of retrieved lymph nodes and the rate of intraoperative complications in gynecologic cancers.

Authors:  Mehmet Coskun Salman; Alp Usubutun; Tulay Ozlu; Kubra Boynukalin; Kunter Yuce
Journal:  J Gynecol Oncol       Date:  2010-03-31       Impact factor: 4.401

4.  Controversies in surgical staging of endometrial cancer.

Authors:  R Seracchioli; S Solfrini; M Mabrouk; C Facchini; N Di Donato; L Manuzzi; L Savelli; S Venturoli
Journal:  Obstet Gynecol Int       Date:  2010-06-23

Review 5.  Diagnostic accuracy of preoperative tests for lymph node status in endometrial cancer: a systematic review.

Authors:  H M P Pelikan; J W Trum; F C H Bakers; R G H Beets-Tan; L J M Smits; R F P M Kruitwagen
Journal:  Cancer Imaging       Date:  2013-07-22       Impact factor: 3.909

6.  How to evaluate the adequacy of staging for nodal-negative epithelial ovarian cancer? Use of nodal staging score.

Authors:  Yuan Xu; Haoran Li; Xiaoxia Tong; Yangyang Pang; Xiaojuan Tong; Luhong Li; Lei Cheng
Journal:  J Gynecol Oncol       Date:  2018-12-04       Impact factor: 4.401

Review 7.  Endometrial carcinoma.

Authors:  W K Huh; J M Straughn; F J Kelly; L C Kilgore
Journal:  Curr Treat Options Oncol       Date:  2001-04

Review 8.  Predictors of limph node metastasis in endometrial cancer.

Authors:  Florin Laurentiu Ignat; Alexandru Irimie; Nicolae Costin; Patriciu Achimas-Cadariu; Ioan Cosmin Lisencu
Journal:  Clujul Med       Date:  2013-11-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.